Submit Deal

BEACON THERAPEUTICS

Summary

Beacon Therapeutics is a gene therapy company dedicated to developing treatments for blinding retinal diseases.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 230 M

Avg. Deal Size£ 115 M

Market Context

Senior Management

Senior Management

Sort

Target: BEACON THERAPEUTICS

Bidder: SYNCONA LTD

3 Service Providers

8 Dealmakers

£ 96 M

Value

Target: BEACON THERAPEUTICS (CONTRACT, MANUFACTURING AND CONTROLS TEAM)

Bidder: ASCEND ADVANCED THERAPIES

6 Service Providers

16 Dealmakers

n/a

Value

Target: BEACON THERAPEUTICS

Bidder: SYNCONA LTD

9 Service Providers

10 Dealmakers

£ 134 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy